« New guidance improves appeals process for Medicare denials | Main | What You Need to Know About Sterilization Services: A Course for Infection Control Practitioners »

February 28, 2008

CDC issues safety advisory for rabies treatment

The Centers for Disease Control and Prevention on Feb. 26 issued a safety advisory concerning a rabies treatment made by Talecris Biotherapeutics Inc. Three lots of the Rabies Immune Globulin do not permit certain dosages to be administered.

The agency said health care providers may continue to administer the pre-filled syringe by following revised directions for use packaged with the affected lots. For more information, see the CDC Health Advisory.

[ via AHA News Now ]

Posted at 10:30 AM in Patient Safety |

Tags: Centers for Disease Control and Prevention, Rabies Immune Globulin, Talecris Biotherapeutics Inc.

|

Comments

Verify your Comment

Previewing your Comment

Posted by:  | 

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Your Information

(Name is required. Email address will not be displayed with the comment.)

Receive MHA News Now Updates Via Daily E-mail

Search MHA News


MHA Facebook Fans

Receive MHA Executive Updates Via Daily E-mail

MHA Photos

  • www.flickr.com
    mhanet's items Go to mhanet's photostream

Twitter

Subscribe to this blog's feed

Categories

Subscribe to my Podcast